D118 Unit 7 Study Guide
Student Name
Western Governors University
D118 Adult Primary Care for the Advanced Practice Nurse
Prof. Name
Date
D118 Unit 7 Study Guide
Differentiation of Laboratory Findings in Anemia
Anemia is characterized by a reduction in hemoglobin concentration, hematocrit, or red blood cell (RBC) count. It can develop due to various causes, making it essential to carefully interpret laboratory findings to determine the underlying etiology. Common causes to consider include acute or chronic blood loss, bone marrow disorders, malignancies, and renal insufficiency.
Acute blood loss, such as hemorrhage or hemolysis, usually shows normal laboratory indices initially but subsequently leads to declining hemoglobin and hematocrit levels. The reticulocyte count typically rises as the bone marrow responds to replace lost cells. In contrast, chronic blood loss, often stemming from gastrointestinal or gynecologic origins, typically results in iron deficiency anemia. This condition is marked by low ferritin levels, reduced serum iron, increased total iron-binding capacity (TIBC), and microcytosis (small RBCs).
Bone marrow disorders like aplastic anemia or myelodysplastic syndromes are often associated with pancytopenia (reduction in all blood cell lines), low reticulocyte counts, and abnormal bone marrow cellularity. Anemia related to malignancy can arise from marrow infiltration, chronic inflammation, or chemotherapy side effects, often presenting as normocytic or mildly microcytic anemia accompanied by elevated inflammatory markers. Lastly, anemia in renal failure results from decreased erythropoietin production, leading to normocytic, normochromic anemia.
What are the key laboratory patterns in common types of anemia?
| Etiology | MCV | Reticulocyte Count | Ferritin | Additional Findings |
|---|---|---|---|---|
| Acute blood loss | Normal | Elevated | Normal | Falling hemoglobin/hematocrit |
| Chronic blood loss (iron deficiency) | Low | Low/Normal | Low | ↑ TIBC |
| Bone marrow failure | Normal/High | Low | Normal | Pancytopenia |
| Malignancy | Normal | Low | Normal/High | ↑ CRP/ESR |
| Renal failure | Normal | Low | Normal | ↓ Erythropoietin |
What Laboratory Values in Metabolic Syndrome Require Nephrology Referral and Why?
In patients with metabolic syndrome, it is crucial to detect early renal impairment to prevent progression to end-stage renal disease. Nephrology referral should be considered when the estimated glomerular filtration rate (eGFR) falls below 30 mL/min/1.73 m² or when albuminuria exceeds 300 mg/g of urinary creatinine.
An eGFR below this threshold corresponds to stage 4 chronic kidney disease, necessitating specialized management to slow kidney damage and prepare for potential renal replacement therapies. Significant albuminuria signals glomerular injury and is independently linked with higher risks of cardiovascular and renal complications (National Kidney Foundation, 2023).
What Is the First-Line Treatment for Generalized Anxiety Disorder?
Pharmacologic first-line treatment for generalized anxiety disorder (GAD) includes antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Medications such as sertraline and escitalopram (SSRIs) and venlafaxine and duloxetine (SNRIs) have shown consistent efficacy in managing anxiety symptoms.
These medications are preferred for their favorable safety profiles and suitability for long-term use. They effectively alleviate both psychological and somatic symptoms of anxiety. In addition, cognitive behavioral therapy (CBT) is recommended alongside medication to maximize therapeutic outcomes.
Differentiation of the Types of Urinary Incontinence
Urinary incontinence includes several distinct types, each defined by different pathophysiologic mechanisms and clinical features. Correct identification is essential as treatment approaches vary accordingly.
| Type | Description |
|---|---|
| Stress incontinence | Leakage of urine during increased intra-abdominal pressure activities such as coughing or lifting |
| Urge incontinence | Sudden, intense urge to urinate followed by involuntary leakage |
| Mixed incontinence | Combination of stress and urge incontinence |
| Overflow incontinence | Continuous or intermittent leakage caused by incomplete bladder emptying |
In Which Patients Should Oxybutynin Be Avoided?
Oxybutynin is an anticholinergic medication used to treat overactive bladder but should be avoided in certain patient groups. It is contraindicated in individuals with myasthenia gravis due to the potential exacerbation of muscle weakness. Additionally, patients with untreated narrow-angle glaucoma, urinary retention related to benign prostatic hyperplasia, or inflammatory bowel diseases such as ulcerative colitis or Crohn’s disease should not use oxybutynin because of its antimuscarinic side effects.
What Medications Are Appropriate for the Treatment of Graves Disease and Why?
Graves disease is an autoimmune disorder characterized by hyperthyroidism caused by thyroid-stimulating immunoglobulins. The primary treatment in the United States is radioactive iodine ablation, which destroys hyperactive thyroid tissue and offers long-term control.
Initial symptom management or treatment for patients who are not candidates for radioactive iodine may involve antithyroid drugs like methimazole. Beta-blockers are commonly used adjunctively to alleviate adrenergic symptoms such as tachycardia and tremors.
Common Clinical Manifestations of Addison’s Disease
Addison’s disease, or primary adrenal insufficiency, occurs due to inadequate cortisol and aldosterone production. Patients often experience chronic symptoms including fatigue, weight loss, low blood pressure, hyperpigmentation, and electrolyte disturbances like hyponatremia and hyperkalemia.
During physical or emotional stress, patients are at risk of an adrenal crisis, a life-threatening emergency characterized by vomiting, severe hypotension, dehydration, and shock. Prompt glucocorticoid therapy is essential to manage this condition.
Educational Plan for a Patient With Type 2 Diabetes
Effective management of type 2 diabetes hinges on patient education covering lifestyle changes, medication adherence, glucose monitoring, and complication prevention. Physical activity is critical as it reduces insulin resistance and increases glucose uptake in muscles. The benefits of exercise on insulin sensitivity may last up to 48 hours, necessitating medication adjustments to prevent hypoglycemia.
Dietary counseling should emphasize balanced nutrition and avoiding excess caloric intake while supporting weight loss. Patients must learn to recognize hypoglycemia, manage illness (“sick-day rules”), and maintain regular follow-up visits. Exercise also plays a preventative role by delaying progression from prediabetes to overt diabetes.
Which Laboratory Test Is Most Important for Monitoring Kidney Function in Diabetes?
The earliest and most important laboratory marker for diabetic kidney disease is microalbuminuria, which indicates increased urinary albumin excretion (>30 mg/24 hours). This marker often precedes symptoms and predicts renal failure and cardiovascular risks.
Testing methods include albumin-to-creatinine ratio in a random urine sample, timed urine collection, or a 24-hour urine test. Diagnosis requires at least two abnormal tests over a 3–6 month period. Ongoing monitoring helps assess the effectiveness of interventions and disease progression.
What Is the Clinical Significance of the Philadelphia Chromosome?
The Philadelphia chromosome is a defining genetic abnormality in chronic myelogenous leukemia (CML). It results from a translocation between chromosomes 9 and 22, creating the BCR-ABL fusion gene. This gene encodes a constitutively active tyrosine kinase that drives uncontrolled proliferation of white blood cells.
CML was the first cancer linked to a specific chromosomal anomaly, and detection of the Philadelphia chromosome has enabled targeted therapies like tyrosine kinase inhibitors, markedly improving patient outcomes.
Clinical Practice Guidelines for Type 1 and Type 2 Diabetes
Distinguishing between type 1 and type 2 diabetes is critical for treatment planning. Type 1 diabetes requires lifelong insulin replacement due to absolute insulin deficiency. Type 2 diabetes management includes lifestyle changes, oral hypoglycemic agents, and insulin as needed.
During pregnancy, insulin remains the standard treatment, but oral agents such as glyburide and metformin are increasingly recognized as safe and effective in select patients. C-peptide testing can aid in differentiating diabetes types when clinical features are ambiguous.
Diagnosis, Laboratory Findings, and Treatment of Hypothyroidism
Hypothyroidism diagnosis is based on elevated thyroid-stimulating hormone (TSH) levels combined with low free thyroxine (T4). Treatment involves thyroid hormone replacement therapy to restore normal thyroid function and suppress excessive TSH production.
In patients with thyroid cancer, TSH suppression is tailored by risk stratification: intermediate and high-risk patients target TSH levels below 0.3 mIU/L, while low-risk patients maintain levels between 0.3 and 2.0 mIU/L.
Medications Used in the Treatment of Depression
Depression is managed with various classes of antidepressants, chosen based on symptoms, comorbid conditions, and drug tolerability.
| Class | Example | Typical Dose Range |
|---|---|---|
| SSRI | Sertraline | 50–200 mg/day |
| SNRI | Venlafaxine | 75–225 mg/day |
| Atypical | Bupropion | 150–300 mg/day |
| TCA | Amitriptyline | 25–150 mg/day |
| MAOI | Phenelzine | 45–90 mg/day |
SSRIs and SNRIs are generally preferred as first-line agents due to their efficacy and safety profiles.
Which Anemia Presents With a Beefy Red Tongue?
Vitamin B12 deficiency anemia, a type of megaloblastic anemia, is classically associated with a smooth, beefy red tongue known as glossitis. Patients may also experience neurological symptoms such as peripheral neuropathy and cognitive impairment. Early diagnosis and treatment are vital to prevent irreversible neurological damage.
References
American Diabetes Association. (2024). Standards of medical care in diabetes—2024. Diabetes Care, 47(Suppl. 1), S1–S350.
Jameson, J. L., Fauci, A. S., Kasper, D. L., Hauser, S. L., Longo, D. L., & Loscalzo, J. (2022). Harrison’s principles of internal medicine (21st ed.). McGraw-Hill.
Katzung, B. G., & Trevor, A. J. (2023). Basic and clinical pharmacology (15th ed.). McGraw-Hill.
Melmed, S., Polonsky, K. S., Larsen, P. R., & Kronenberg, H. M. (2020). Williams textbook of endocrinology (14th ed.). Elsevier.
National Kidney Foundation. (2023). KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements.
World Health Organization. (2022). Nutritional anaemias: Tools for effective prevention and control. WHO Press.